Bayer: Clinical Trials & Research Profile
Biopharma Industry (Leverkusen, DE / Whippany, NJ) · Primary Focus: Rare Genetic, Women's Health, and Other
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Leverkusen, DE / Whippany, NJ) |
| Primary Therapeutic Area | Rare Genetic, Women's Health, and Other |
| Active Phase II & III Studies | 25 active (13 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 107 (51 with California sites) |
| Completed vs Early-Stopped Studies | 66 completed / 16 stopped (15.0% stop rate) |
| Median Closed Enrollment | 153 participants |
| FDA Drugs@FDA Original Approvals | 98 all-time (9 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 99.7% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Bayer across sibling Meru public-data platforms.
- Cliff Ledger FDA Orange BookBayer Patent Cliff & CMS Rx Portfoliorx.meruai.co →
- Predicate Ledger FDA 510(k)Bayer FDA 510(k) & Recall Cohortdevices.meruai.co →
- ERISA Ledger DOL Form 5500Bayer 401(k) & Form 5500 Planerisa.meruai.co →
- Plume Ledger EPA TRI & RCRABayer U.S. TRI & RCRA Facilitieshazmat.meruai.co →
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk